Rani Therapeutics Holdings, Inc. (RANI)

NASDAQ: RANI · IEX Real-Time Price · USD

3.870

+0.050 (1.31%)

At close: Jul 2, 2024, 4:00 PM

3.950

+0.080 (2.07%)

After-hours: Jul 2, 2024, 4:52 PM EDT

RANI Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	195	166	291	801	-
Market Cap Growth	-38.82%	-43.00%	-63.65%	-	-
Enterprise Value	191	148	223	684	-69
PE Ratio	-	-4.89	-9.52	-96.17	-
PS Ratio	-	-	-	294.88	-
PB Ratio	26.38	12.90	7.90	16.90	-
P/FCF Ratio	-3.15	-3.16	-6.05	-24.46	-
P/OCF Ratio	-3.22	-3.24	-6.26	-24.85	-
EV/Sales Ratio	-	-	-	251.65	-149.97
EV/EBITDA Ratio	-5.87	-5.46	-7.92	-93.32	4.34
EV/EBIT Ratio	-5.44	-5.11	-7.57	-87.39	4.19
EV/FCF Ratio	-3.07	-2.81	-4.63	-20.88	4.29
Debt / Equity Ratio	4.79	2.34	0.82	-	-0.03
Debt / EBITDA Ratio	-1.37	-1.11	-1.07	-	-0.24
Debt / FCF Ratio	-0.72	-0.57	-0.63	-	-0.23
Quick Ratio	2.96	6.08	20.45	44.49	14.09
Current Ratio	3.10	6.37	20.96	45.30	14.12
Asset Turnover	0	0	0	0.03	0.01
Interest Coverage	-5.40	-5.68	-27.49	-16.79	-133.42
Return on Equity (ROE)	-213.70%	-159.40%	-67.90%	23.20%	15.90%
Return on Assets (ROA)	-49.90%	-44.10%	-28.10%	-7.90%	-32.60%
Return on Capital (ROIC)	-148.61%	-153.84%	-94.61%	-108.83%	15.10%
Earnings Yield	-16.95%	-20.47%	-10.50%	-1.04%	-
FCF Yield	-25.36%	-31.61%	-16.53%	-4.09%	-
Buyback Yield / Dilution	-3.15%	-7.09%	-21.93%	58.34%	-
Total Shareholder Return	-3.15%	-7.09%	-21.93%	58.34%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).